این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
جمعه 21 آذر 1404
Research in Pharmaceutical Sciences
، جلد ۱۵، شماره ۶، صفحات ۵۷۱-۵۸۲
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
Bufo viridis secretions improve anxiety and depression-like behavior following intracerebroventricular injection of amyloid β
چکیده انگلیسی مقاله
Background and purpose: Venenum Bufonis is a Chinese traditional medicine produced from the glandular secretions of toads that contain biogenic amines, which have anti-inflammatory properties. The present study aimed to examine the effect of Bufo viridis secretions (BVS) on anxiety and depression-like behavior and hippocampal senile plaques volume in an animal model of Alzheimer’s disease (AD). Experimental approach: Thirty-eight male Wistar rats were used. AD was induced by amyloid-beta (Aβ 1-42 )(10 µg/2 µL, intracerebroventricular injection, icv) and then BVS at 20, 40, and 80 mg/kg were injected intraperitoneally (ip) in six equal intervals over 21 days. Anxiety and depression-like behavior were assessed using behavioral tests including open field test (OFT), elevated plus maze (EPM), and forced swimming test (FST) 21 days after the surgery. The volume of senile plaques was assessed based on the Cavalieri principle. Findings/Results: Results of the OFT showed that the central crossing number and the time in the AD group were significantly decreased compared to the sham group ( P ˂ 0.01 and P ˂ 0.001, respectively). Also, the values of these two parameters significantly increased in the AD + BVS80 group than the AD group ( P ˂ 0.05 and P ˂ 0.001, respectively). The time spent in the closed arm in the EPM dramatically increased in the AD group compared to the sham group ( P ˂ 0.05) and significantly decreased in the AD + BVS80 group compared to the AD group ( P ˂ 0.05). Results of the FST indicated that immobility time had a reduction in the AD + BVS20 ( P ˂ 0.01), AD + BVS40, and AD + BVS80 groups compared to the AD group ( P < 0.001). The volume of senile plaques in the hippocampus showed a reduction in the treatment groups in comparison with the AD group ( P < 0.001 for all). Conclusion and implications: Results revealed that BVS injection could improve symptoms of anxiety and depression and decrease senile plaques in the hippocampus in an animal model of AD.
کلیدواژههای انگلیسی مقاله
Keywords, Amyloid-β1-42,Bufo viridis secretion,Depression,Elevated plus-maze,Forced swimming test,Open field test.
نویسندگان مقاله
| Shima Shirzad
1Department of Biology, Faculty of Science, Mashhad Branch, Islamic Azad University, Mashhad, I.R. Iran.
| Ali Neamati
2Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, I.R. Iran. 3Department of Neuroscience, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, I.R. Iran.
| Farzaneh Vafaee
2Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, I.R. Iran. 3Department of Neuroscience, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, I.R. Iran.
| Hamed Ghazavi
نشانی اینترنتی
http://rps.mui.ac.ir/index.php/jrps/article/view/2034
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
Original Article
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات